U.S. FDA approves new breast cancer drug that could slow disease significantly – National
By Kunal Das and Christy Santhosh Reuters Posted July 14, 2026 4:03 pm 1 min read Descrease article font size Increase article font size The U.S. FDA has approved Celcuity’s drug for an advanced form of breast cancer, the regulator said on Tuesday, making it the company’s first product to gain market entry and sending…